Search
for
Sort by
Research 30 of 1000+
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Recurrent inverse necrotizing infundibular crystalline folliculitis
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Cutaneous lupus erythematosus induced by tislelizumab
- Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
- Cutaneous toxicities of new treatments for melanoma
- 576 INTASYL PH-762: Intratumoral immunotherapy targeting PD-1
- 575 INTASYL self-delivering RNAi: A flexible platform to treat dermatological malignancies
- Cemiplimab-Induced Alopecia Areata
- Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- Management of Toxicities of Targeted Therapies
- Pembrolizumab-Induced Autoimmune Hepatitis
- SUN-911 Immunotherapy Use in Adrenocortical Carcinoma with Encouraging Results- a Case Report
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023
- Synthesis of Spiro[cyclohexane-1,2?-[2H]indene] derivatives as inhibitors of steroid 5?-reductase
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Effect of C-ring modifications in benzo[c]quinolizin-3-ones, new selective inhibitors of human 5α-reductase 1
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment